Aspira Pathlab & Diagnostics Limited

Equities

ASPIRA

INE500C01017

Healthcare Facilities & Services

Market Closed - Bombay S.E. Other stock markets 11:01:01 03/06/2024 BST			5-day change	1st Jan Change
31.46 ^INR	+1.48%		+7.70%	-19.70%

05-28	Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
04-03	Aspira Pathlab Forms New Limited Liability Partnership	MT

Orangutan Gaming Private Limited announced that it expects to receive INR 10 million in funding from Aspira Pathlab & Diagnostics Limited

May 27, 2022

Orangutan Gaming Private Limited announced that it will issue up to 1,000,000 compulsorily convertible preferred shares at a price of INR 10 per share for gross proceeds of INR 10,000,000 on May 28, 2022. The transaction will include participation from Aspira Pathlab & Diagnostics Limited. The transaction has been approved by board of directors of the investor.

Latest news about Aspira Pathlab & Diagnostics Limited

Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-28	CI
Aspira Pathlab Forms New Limited Liability Partnership	04-03	MT
Aspira Pathlab Opens Two Diagnostic Centers in India	04-01	MT
Aspira Pathlab Opens New Diagnostic Center in Mumbai, India	03-04	MT
Aspira Pathlab & Diagnostics Limited Announces Resignation of Arvind Bhanushali as Non-Executive, Non-Independent Director and as Member of Audit Committee	02-13	CI
Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Aspira Pathlab & Diagnostics Limited Appoints Manas Mengar as the Member of Nomination and Remuneration Committee	17/10/23	CI
Aspira Pathlab & Diagnostics Limited Announces Completion of Tenure of Subhash Raghunath Salunke as Non-Executive and Independent Director	28/09/23	CI
Aspira Pathlab & Diagnostics Limited Appoints Manas Mengar as Non-Executive and Independent Director	27/09/23	CI
Aspira Pathlab & Diagnostics Limited Announces Appointment of Krupali Shah as Company Secretary Cum Compliance Officer	12/08/23	CI
Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	12/08/23	CI
Aspira Pathlab & Diagnostics Limited Announces the Resignation of Priya Pandey as Company Secretary and Compliance Officer, Key Managerial Personnel	24/06/23	CI
Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/05/23	CI
Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
Aspira Pathlab & Diagnostics Limited Approves the Change in Designation of Arvind Bhanushali from Executive Director to Non-Executive Director	12/11/22	CI
Aspira Pathlab & Diagnostics Gets Board Approval to Invest in E-Sports Company	30/05/22	MT
Orangutan Gaming Private Limited announced that it expects to receive INR 10 million in funding from Aspira Pathlab & Diagnostics Limited	27/05/22	CI
Aspira Pathlab & Diagnostics Limited Approves Appointment of Priya Pandey as Company Secretary and Compliance Officer of the Company	16/04/22	CI
Aspira Pathlab & Diagnostics Limited Announces the Resignation of Darshan Sawant as Company Secretary and Compliance Officer	19/03/22	CI
Aspira Pathlab & Diagnostics Limited Announces Appointment of Darshana Sawant as Company Secretary and Compliance Officer of Company	13/11/21	CI
Aspira Pathlab & Diagnostics Limited Announces Resignation of Devyangi Patel as Company Secretary & Compliance Officer, Effective September 24, 2021	23/09/21	CI
Aspira Pathlab & Diagnostics Limited Reports Unaudited Earnings Results for the Quarter Ended June 30, 2021	14/08/21	CI
Aspira Pathlab & Diagnostics Limited Announces Resignation of Yash Bhanushali as Executive Director	05/06/21	CI
Aspira Pathlab & Diagnostics Limited Announces Resignation of Abhay Chowdhary as Director	05/06/21	CI
Aspira Pathlab & Diagnostics Limited Accepts Resignation of Vandana Bhansali, Non-Executive and Non-Independent Director	05/06/21	CI

Chart Aspira Pathlab & Diagnostics Limited

Duration

Period

Chart Aspira Pathlab & Diagnostics Limited

More charts

Company Profile

Aspira Pathlab & Diagnostics Limited is an India-based company, which is engaged in the business of running, owning, managing, and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include COVID-19 tests, health packages and pathology tests. Its COVID-19 tests include Shanti Screening Test, COVID-19 Antibody Test, COVID-19 Surveillance Profile, COVID-19 RT-PCR Test, COVID-19 Detection Profile 1, and COVID-19 Detection Profile 2.

Sector

Healthcare Facilities & Services

Calendar

11/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
ASPIRA PATHLAB & DIAGNOSTICS LIMITED	-19.70%	3.82M
SONIC HEALTHCARE LIMITED	-24.66%	7.76B
RADNET, INC.	+68.65%	4.33B
SYNLAB AG	-2.80%	2.64B
DR. LAL PATHLABS LIMITED	+3.74%	2.63B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-46.17%	2.16B
NEOGENOMICS, INC.	-15.27%	1.75B
FLEURY S.A.	-22.12%	1.46B
METROPOLIS HEALTHCARE LIMITED	+13.62%	1.17B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.81%	1.14B

Medical & Diagnostic Laboratories